Summary

Assisted Reproductive Technology Market Trends & Summary

Assisted Reproductive Technology Market is expected to reach US$ 49.30 billion 2033 from US$ 27.76 billion in 2024, with a CAGR of 6.59% from 2025 to 2033. The rise of the assisted reproductive technology sector is mostly being driven by advancements in medical technology, rising infertility rates, delayed childbearing, increased awareness, shifting societal standards, and government assistance.

The report Assisted Reproductive Technology Market & Forecast covers by Type (In-Vitro Fertilization (IVF), Artificial Insemination), End Users (Hospitals, Fertility Clinics, Other End Users), Country and Company Analysis 2025-2033.


Assisted Reproductive Technology Industry Overview

Assisted reproductive technology (ART) sits at the vanguard of contemporary medical developments, altering the landscape of fertility treatments. It helps people and couples overcome infertility issues as a general phrase that encompasses a variety of techniques and interventions. From in vitro fertilization (IVF) to intrauterine insemination (IUI), ART treatments harness cutting-edge medical science to realize the dream of parenthood. In addition to addressing biological complications, this quickly developing discipline gives those who are having trouble conceiving naturally hope and opportunities. Beyond the medical field, ART has a significant influence on how family life and reproductive health are portrayed in the contemporary period.

Advances in medical technology, rising infertility rates, delayed pregnancies as a result of lifestyle changes, more knowledge of fertility treatments, and better ART procedure success rates are all factors driving the expansion of the assisted reproductive technology (ART) market. The market is expanding as a result of favorable government regulations, easier access to fertility treatments, rising demand for genetic screening, and public acceptance of assisted reproduction, all of which improve the effectiveness and accessibility of these services.


Growth Drivers for the Assisted Reproductive Technology Market

Rising Infertility Rates

One major factor propelling the market for assisted reproductive technology (ART) is the rise in infertility rates. As the number of people affected by infertility rises globally, so does the need for ART therapies. 11% of women who had previously given birth were unable to do so again, and 2% of women between the ages of 20 and 44 were unable to give birth at all, according to data released by the National Library of Medicine in December 2022. The Middle East, North Africa, and Eastern Europe have especially high rates of infertility. The need for ART treatments is growing as a result of the rising incidence of infertility caused by age, medical disorders, and changes in lifestyle. The need for ART therapies is anticipated to increase as more people look for ways to overcome infertility, which will support the market's growth in the upcoming years.


Advancements in Medical Technology

The market for assisted reproductive technology (ART) is mostly driven by developments in medical technology. Developments in methods such as genetic screening, egg/sperm freezing, in-vitro fertilization (IVF), and embryo cryopreservation have greatly increased treatment options and success rates. Furthermore, treatments are now safer and more successful thanks to the development of non-invasive techniques like genetic testing of embryos and improvements in fertility preservation. By addressing the various demands of individuals and couples dealing with infertility issues, these technological advancements have boosted patient trust, decreased the danger of problems, and extended ART's accessibility, propelling the market's expansion.

In June 2022, with the introduction of HavenCryo, a long-term reproductive tissue and cryopreservation storage solution that provides a distinctive experience for patients and fertility specialists, Inception Fertility broadened its ecosystem. Technology for assisted reproductive technologies (ART) is part of it.


Growing Awareness and Acceptance

The market for assisted reproductive technology (ART) is expected to develop significantly due to rising awareness and societal acceptance. More people are seeking ART treatments as a result of increased awareness of fertility alternatives provided by the media, medical experts, and support groups. The need for ART services is growing as perceptions of non-traditional family arrangements, such as same-sex partnerships and single parents, become more accepting. Public trust in these technologies has also increased as a result of increased visibility of ART success stories. Fertility treatments are now more widely accepted due to increased awareness and wider cultural acceptance, which has increased the use of ART and fueled industry expansion.


Challenges in the Assisted Reproductive Technology Market

High Costs

In the market for assisted reproductive technology (ART), high costs continue to be a major obstacle. Many insurance policies do not cover the full cost of procedures like IVF, which can be costly and frequently surpass several thousand dollars per cycle. Because of this, many people still cannot afford ART, which restricts access, particularly for those who are uninsured or have low incomes. Since many couples experience several cycles before finding success, the financial strain can result in emotional and psychological stress.


Access in Developing Regions

Due to a lack of specialized clinics, poor medical professional training, and inadequate healthcare infrastructure, access to assisted reproductive technology (ART) is restricted in many developing nations. Furthermore, many people are unable to pay for treatments due to financial constraints, and ART services may be discouraged by social or cultural stigma. The expansion of ART in low- and middle-income nations, where the demand for such services is rising, is hampered by these constraints, which make it extremely difficult to provide fair access to fertility treatments.


Assisted Reproductive Technology Market Overview by Regions

With North America and Europe leading the way in technological developments, accessibility, and high service demand, the market for assisted reproductive technology (ART) is expanding globally. Asia-Pacific shows rapid growth due to rising infertility rates and improving healthcare infrastructure. While growing awareness is propelling market expansion in the Middle East and Africa, these regions nevertheless confront obstacles like restricted access and cultural restrictions.


Assisted Reproductive Technology Market Overview by Regions

United States Assisted Reproductive Technology Market

Due to rising awareness, technological advancements, and high rates of infertility, the US market for assisted reproductive technology (ART) is among the biggest and most developed in the world. Due to postponed childbearing and growing public acceptance of ART, there is a significant demand for essential services such in-vitro fertilization (IVF), egg freezing, and genetic screening. High treatment costs continue to be a major obstacle, even though insurance coverage in some areas supports the industry. In an effort to increase its footprint in the West Coast reproductive market, Ivy reproductive announced in October 2024 that it had acquired the Northern California Fertility Medical Center. With this action, patients seeking fertility treatments will have easier access to state-of-the-art ART services. Through these expansions, as well as increased focus on patient-centered treatment, higher success rates, and continuous research, the U.S. market is still rising.


Germany Assisted Reproductive Technology Market

The market for assisted reproductive technology (ART) in Germany is well-established, bolstered by a robust regulatory environment and cutting-edge healthcare infrastructure. With excellent success rates, the nation provides a variety of fertility procedures, such as IVF, egg freezing, and genetic testing. Although coverage varies by area, the German government does offer some assistance with fertility treatments. The need for ART therapies is being driven by rising rates of infertility and postponed childbirth. But there are still issues with ART's ethical and legal aspects, like the use of donor gametes. All things considered, Germany continues to dominate the European ART market.


India Assisted Reproductive Technology Market

The market for assisted reproductive technology (ART) in India is expanding quickly due to factors like increased infertility rates, shifting social mores, and growing knowledge of fertility treatments. The nation benefits from a sizable population and a developing healthcare system, as evidenced by the rise in fertility clinics providing surrogacy, IVF, and egg freezing services. India also draws medical tourists because of its skilled medical staff and reasonably priced treatments. But there are still issues, such as inconsistent regulations, social stigma, and inadequate insurance coverage. In spite of this, the Indian ART industry is anticipated to keep growing.


Saudi Arabia Assisted Reproductive Technology Market

Growing rates of infertility, more knowledge of fertility treatments, and societal acceptance of ART are driving the growth of the Saudi Arabian market for assisted reproductive technology (ART). Access to procedures like IVF, egg freezing, and genetic testing has improved as a result of government healthcare funding and support for ART services, as well as an increase in private fertility clinics. Saudi Arabia's ART market is anticipated to keep growing in the upcoming years due to rising demand and continuous advancements in healthcare infrastructure.


Assisted Reproductive Technology Market Segments

Type – Market breakup in 2 viewpoints:
1. In-Vitro Fertilization (IVF)
2. Artificial Insemination


End Users – Market breakup in 3 viewpoints:
1. Hospitals
2. Fertility Clinics
3. Other End Users


Countries – Market breakup from 25 Country viewpoints:
North America

1. United States
2. Canada

Europe

1. France
2. Germany
3. Italy
4. Spain
5. United Kingdom
6. Belgium
7. Netherlands
8. Turkey

Asia Pacific

1. China
2. Japan
3. India
4. Australia
5. South Korea
6. Thailand
7. Malaysia
8. Indonesia
9. New Zealand

Latin America

1. Brazil
2. Mexico
3. Argentina

Middle East & Africa

1. South Africa
2. Saudi Arabia
3. UAE


All the Key players have been covered from 5 Viewpoints:
• Overview
• Key Persons
• Recent Development & Strategies
• Product Portfolio
• Financial Insights


Company Analysis:
1. Thermo Fisher Scientific Inc.
2. Sumitomo Mitsui Financial Group, Inc.
3. CooperSurgical, Inc.
4. Fujifilm Holdings Corporation
5. Merck KGaA
6. Progyny Inc.
7. Cosmos Biomedical Ltd.


Key Questions Answered in Report:
1. How big is the assisted reproductive technology industry?
The global assisted reproductive technology market size was valued at US$ 27.76 billion in 2024 and is expected to reach US$ 49.30 billion in 2033.

2. What is the assisted reproductive technology industry growth rate?
The global assisted reproductive technology market is expected to expand at a compound annual growth rate (CAGR) of 6.59% from 2025 to 2033.

3. Who are the key players in assisted reproductive technology industry?
The top assisted reproductive technology companies are Thermo Fisher Scientific Inc., Sumitomo Mitsui Financial Group, Inc., CooperSurgical, Inc., Fujifilm Holdings Corporation, Merck KGaA, Progyny Inc., Cosmos Biomedical Ltd.

4. What are the factors driving the assisted reproductive technology industry?
Advancements in medical technology, rising infertility rates, delayed childbearing, increased awareness, changing societal norms, and government support are key factors driving the growth of the assisted reproductive technology industry.

5. Which Region held the largest market share in the assisted reproductive technology industry?
North America is expected to hold the largest market share in the industry.

6. What segments are covered in the assisted reproductive technology market report?
Type, End Users and Countries segment are covered in this report.

ページTOPに戻る

Table of Contents

1. Introduction


2. Research & Methodology


3. Executive Summary


4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges


5. Global Assisted Reproductive Technology Market


6. Market Share Analysis
6.1 Type
6.2 End Users
6.3 Country


7. Type
7.1 In-Vitro Fertilization (IVF)
7.2 Artificial Insemination


8. End Users
8.1 Hospitals
8.2 Fertility Clinics
8.3 Other End Users


9. Country
9.1 North America

9.1.1 United States
9.1.2 Canada

9.2 Europe

9.2.1 France
9.2.2 Germany
9.2.3 Italy
9.2.4 Spain
9.2.5 United Kingdom
9.2.6 Belgium
9.2.7 Netherlands
9.2.8 Turkey

9.3 Asia Pacific

9.3.1 China
9.3.2 Japan
9.3.3 India
9.3.4 Australia
9.3.5 South Korea
9.3.6 Thailand
9.3.7 Malaysia
9.3.8 Indonesia
9.3.9 New Zealand

9.4 Latin America

9.4.1 Brazil
9.4.2 Mexico
9.4.3 Argentina

9.5 Middle East & Africa

9.5.1 South Africa
9.5.2 Saudi Arabia
9.5.3 UAE


10. Porter’s Five Analysis
10.1 Bargaining Power of Buyers
10.2 Bargaining Power of Suppliers
10.3 Degree of Rivalry
10.4 Threat of New Entrants
10.5 Threat of Substitutes


11. SWOT Analysis
11.1 Strength
11.2 Weakness
11.3 Opportunity
11.4 Threat


12. Company Analysis
12.1 Thermo Fisher Scientific Inc.
12.1.1 Overview
12.1.2 Key Persons
12.1.3 Recent Development & Strategies
12.1.4 Product Portfolio
12.1.5 Financial Insights

12.2 Sumitomo Mitsui Financial Group, Inc.
12.2.1 Overview
12.2.2 Key Persons
12.2.3 Recent Development & Strategies
12.2.4 Product Portfolio
12.2.5 Financial Insights

12.3 CooperSurgical, Inc.
12.3.1 Overview
12.3.2 Key Persons
12.3.3 Recent Development & Strategies
12.3.4 Product Portfolio
12.3.5 Financial Insights

12.4 Fujifilm Holdings Corporation
12.4.1 Overview
12.4.2 Key Persons
12.4.3 Recent Development & Strategies
12.4.4 Product Portfolio
12.4.5 Financial Insights

12.5 Merck KGaA
12.5.1 Overview
12.5.2 Key Persons
12.5.3 Recent Development & Strategies
12.5.4 Product Portfolio
12.5.5 Financial Insights

12.6 Progyny Inc.
12.6.1 Overview
12.6.2 Key Persons
12.6.3 Recent Development & Strategies
12.6.4 Product Portfolio
12.6.5 Financial Insights

12.7 Cosmos Biomedical Ltd.
12.7.1 Overview
12.7.2 Key Persons
12.7.3 Recent Development & Strategies
12.7.4 Product Portfolio